Venture into the world of corporate biotech in Canada. The year is 2020, the first year of the COVID-19 pandemic. Andrew Casey, President of BIOTECanada weighs in on the industry, government policy, investment trends, and introduces the idea of a Canadian National Health Sciences Fund, a government sponsored fund dedicated to promoting biotech in Canada along with accelerators who help incubate these companies. Awaiting the creation of a foundational Life Sciences company in Canada, Casey tells us how he thinks this company will emerge.